Measurement of midregional pro-atrial natriuretic peptide to discover atrial fibrillation in patients with ischemic stroke
Background Midregional pro-atrial natriuretic peptide (MR-proANP) is a promising
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS). Objectives …
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS). Objectives …
Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke
J Schweizer, M Arnold, IR König, A Bicvic, LP Westphal… - 2022 - digital.csic.es
[Results] Between October 1, 2014, and October 31, 2017, this study recruited 1,759
patients. Log10MR-proANP levels were associated with CE stroke (OR: 7.96; 95% CI: 4.82 …
patients. Log10MR-proANP levels were associated with CE stroke (OR: 7.96; 95% CI: 4.82 …
Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke
J Schweizer, M Arnold, IR König… - Journal of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Midregional pro-atrial natriuretic peptide (MR-proANP) is a promising
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS). Objectives …
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS). Objectives …
[HTML][HTML] Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke
J Schweizer, M Arnold, IR König, A Bicvic… - Journal of the American …, 2022 - Elsevier
Background Midregional pro-atrial natriuretic peptide (MR-proANP) is a promising
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS). Objectives …
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS). Objectives …
Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke
J Schweizer, M Arnold, IR König, A Bicvic… - Journal of the American …, 2022 - zora.uzh.ch
BACKGROUND: Midregional pro-atrial natriuretic peptide (MR-proANP) is a promising
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS) …
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS) …
Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.
J Schweizer, M Arnold, IR König, A Bicvic… - Journal of the …, 2022 - boris.unibe.ch
BACKGROUND Midregional pro-atrial natriuretic peptide (MR-proANP) is a promising
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS) …
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS) …
Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.
J Schweizer, M Arnold, IR König, A Bicvic… - Journal of the …, 2022 - europepmc.org
Background Midregional pro-atrial natriuretic peptide (MR-proANP) is a promising
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS). Objectives …
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS). Objectives …
Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke
J Schweizer, M Arnold, IR König, A Bicvic, LP Westphal… - 2022 - ir.lib.uth.gr
Background: Midregional pro-atrial natriuretic peptide (MR-proANP) is a promising
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS). Objectives …
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS). Objectives …
Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke
J Schweizer, M Arnold, IR König… - Journal of the …, 2022 - research.uni-luebeck.de
BACKGROUND: Midregional pro-atrial natriuretic peptide (MR-proANP) is a promising
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS) …
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS) …
Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke
J Schweizer, M Arnold, IR König… - Journal of the …, 2022 - research.uni-luebeck.de
BACKGROUND: Midregional pro-atrial natriuretic peptide (MR-proANP) is a promising
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS) …
biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS) …